H.R.5202: Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018

About This Bill

  • Introduced March 7, 2018
  • Latest Major Action May 9, 2018

Bill Summary

Ensuring Patient Access to Substance Use Disorder Treatments Act of 2018 This bill amends the Controlled Substances Act to allow a pharmacy to deliver a controlled substance to a practitioner, in accordance with a prescription, to be administered to a specific patient for maintenance or detoxification treatment or through an intrathecal pump. The bill directs the Government Accountability Office to report to Congress on access to and the...

(Source: Congressional Research Service)

What Lawmakers Are Saying About This Bill

There are 2 statements associated with H.R.5202.

Bill Actions

Date Description
May 9
Ordered to be Reported by Voice Vote.
May 9
Committee Consideration and Mark-up Session Held.
April 25
Forwarded by Subcommittee to Full Committee by Voice Vote .
April 25
Subcommittee Consideration and Mark-up Session Held.
April 6
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
March 9
Referred to the Subcommittee on Health.
March 7
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
March 7

Introduced in the House by Ryan Costello (R-Pa.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page